Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesscortical actin cytoskeleton organization

ROCK1 CALR FHOD1

2.16e-0545253GO:0030866
GeneOntologyBiologicalProcesscortical cytoskeleton organization

ROCK1 CALR FHOD1

4.41e-0557253GO:0030865
GeneOntologyBiologicalProcessnegative regulation of motor neuron apoptotic process

ROCK1 ERBB3

1.09e-0413252GO:2000672
GeneOntologyBiologicalProcessprotein folding in endoplasmic reticulum

CALR CANX

1.09e-0413252GO:0034975
GeneOntologyBiologicalProcessregulation of motor neuron apoptotic process

ROCK1 ERBB3

2.64e-0420252GO:2000671
GeneOntologyBiologicalProcessMHC protein complex assembly

CALR HLA-DQA1

2.92e-0421252GO:0002396
GeneOntologyBiologicalProcesspeptide antigen assembly with MHC protein complex

CALR HLA-DQA1

2.92e-0421252GO:0002501
GeneOntologyCellularComponentlumenal side of endoplasmic reticulum membrane

CALR HLA-DQA1 CANX

9.64e-0635253GO:0098553
GeneOntologyCellularComponentlumenal side of membrane

CALR HLA-DQA1 CANX

2.52e-0548253GO:0098576
GeneOntologyCellularComponentbleb

ROCK1 FHOD1

6.14e-0510252GO:0032059
GeneOntologyCellularComponentendoplasmic reticulum quality control compartment

CALR CANX

1.85e-0417252GO:0044322
MousePhenoabnormal MHC II cell surface expression on macrophages

CIITA HLA-DQA1

4.88e-058192MP:0005040
MousePhenoabnormal macrophage antigen presentation

CIITA HLA-DQA1

7.83e-0510192MP:0002454
Domain-

CALR CANX

5.16e-0632522.10.250.10
DomainCALRETICULIN_REPEAT

CALR CANX

5.16e-063252PS00805
DomainCalret/calnex

CALR CANX

1.03e-054252IPR001580
DomainCalreticulin

CALR CANX

1.03e-054252PF00262
DomainCALRETICULIN_1

CALR CANX

1.03e-054252PS00803
DomainCALRETICULIN_2

CALR CANX

1.03e-054252PS00804
DomainCalret/calnex_CS

CALR CANX

1.03e-054252IPR018124
DomainCalreticulin/calnexin_P_dom

CALR CANX

1.72e-055252IPR009033
DomainER_TARGET

P3H3 CALR

1.79e-0347252PS00014
Domain-

CALR CANX

7.12e-03952522.60.120.200
DomainZnf_FYVE_PHD

KDM5B FGD6

1.64e-02147252IPR011011
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

CIITA CALR HLA-DQA1 CANX

6.36e-0688204M16004
PathwayREACTOME_CALNEXIN_CALRETICULIN_CYCLE

CALR CANX

4.00e-057202MM15592
PathwayREACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE

CALR CANX

1.99e-0415202MM15175
PathwayREACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION

RILP HLA-DQA1 CANX

5.59e-04116203MM14855
PathwayREACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC

CALR CANX

5.63e-0425202MM15713
PathwayREACTOME_CALNEXIN_CALRETICULIN_CYCLE

CALR CANX

6.09e-0426202M907
PathwayREACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION

RILP HLA-DQA1 CANX

7.11e-04126203M705
PathwayREACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC

CALR CANX

7.59e-0429202M1062
PathwayREACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE

CALR CANX

1.11e-0335202M918
Pubmed

The contribution of de novo coding mutations to autism spectrum disorder.

DIP2A KDM5B SRCAP

2.66e-071825325363768
Pubmed

Calreticulin is required for development of the cumulus oocyte complex and female fertility.

CALR CANX

4.96e-07225226388295
Pubmed

Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control.

CALR CANX

4.96e-07225214731400
Pubmed

The mammalian formin FHOD1 is activated through phosphorylation by ROCK and mediates thrombin-induced stress fibre formation in endothelial cells.

ROCK1 FHOD1

4.96e-07225218239683
Pubmed

Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin.

CALR CANX

4.96e-0722528550632
Pubmed

Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum.

CALR CANX

4.96e-07225216467570
Pubmed

Compromised calnexin function in calreticulin-deficient cells.

CALR CANX

4.96e-07225212727205
Pubmed

Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma.

CALR CANX

4.96e-07225214732231
Pubmed

Calnexin, calreticulin and the folding of glycoproteins.

CALR CANX

4.96e-07225217708944
Pubmed

Revisiting the specificity of the MHC class II transactivator CIITA in vivo.

CIITA HLA-DQA1

1.49e-06325216703565
Pubmed

Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin.

CALR CANX

1.49e-0632529312001
Pubmed

The Diaphanous-related Formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing.

ROCK1 FHOD1

1.49e-06325218694941
Pubmed

RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy.

CALR CANX

1.49e-06325236224200
Pubmed

Circulating, soluble forms of major histocompatibility complex antigens are not exosome-associated.

CIITA HLA-DQA1

1.49e-06325217072917
Pubmed

Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway.

CALR CANX

1.49e-06325211795871
Pubmed

Substrate specificity of the oxidoreductase ERp57 is determined primarily by its interaction with calnexin and calreticulin.

CALR CANX

1.49e-06325219054761
Pubmed

The measles virus (MV) glycoproteins interact with cellular chaperones in the endoplasmic reticulum and MV infection upregulates chaperone expression.

CALR CANX

1.49e-06325211765911
Pubmed

ER-60 domains responsible for interaction with calnexin and calreticulin.

CALR CANX

1.49e-06325215236594
Pubmed

Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin and calreticulin.

CALR CANX

1.49e-06325212052826
Pubmed

The glut 1 glucose transporter interacts with calnexin and calreticulin.

CALR CANX

1.49e-0632528662691
Pubmed

Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter.

CALR CANX

1.49e-06325210364189
Pubmed

Trafficking-deficient G572R-hERG and E637K-hERG activate stress and clearance pathways in endoplasmic reticulum.

CALR CANX

1.49e-06325222242185
Pubmed

Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity.

CIITA HLA-DQA1

2.97e-06425218799151
Pubmed

A novel quality control compartment derived from the endoplasmic reticulum.

CALR CANX

2.97e-06425211408579
Pubmed

In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein.

CALR CANX

2.97e-06425218791162
Pubmed

Endoplasmic reticulum glucosidase II is composed of a catalytic subunit, conserved from yeast to mammals, and a tightly bound noncatalytic HDEL-containing subunit.

CALR CANX

2.97e-0642528910335
Pubmed

MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.

CIITA HLA-DQA1

2.97e-06425220696698
Pubmed

Cell surface targeting of myelin oligodendrocyte glycoprotein (MOG) in the absence of endoplasmic reticulum molecular chaperones.

CALR CANX

2.97e-06425221172390
Pubmed

MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.

CIITA HLA-DQA1

2.97e-06425216849401
Pubmed

Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain.

CALR CANX

2.97e-06425212239218
Pubmed

The low-density lipoprotein receptor-related protein associates with calnexin, calreticulin, and protein disulfide isomerase in receptor-associated-protein-deficient fibroblasts.

CALR CANX

2.97e-06425214980518
Pubmed

Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP/GRP78 and not calnexin.

CALR CANX

2.97e-06425215677452
Pubmed

Association of the thyrotropin receptor with calnexin, calreticulin and BiP. Efects on the maturation of the receptor.

CALR CANX

2.97e-06425212383251
Pubmed

The role of N-glycan in folding, trafficking and pathogenicity of myelin oligodendrocyte glycoprotein (MOG).

CALR CANX

2.97e-06425225541284
Pubmed

Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin.

CALR CANX

2.97e-0642529525969
Pubmed

Targeted mutation of the mouse Grp94 gene disrupts development and perturbs endoplasmic reticulum stress signaling.

CALR CANX

4.95e-06525220520781
Pubmed

ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin.

CALR CANX

4.95e-06525210436013
Pubmed

Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance.

CIITA HLA-DQA1

4.95e-06525224842370
Pubmed

Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice.

CIITA HLA-DQA1

4.95e-0652529491996
Pubmed

The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo.

CALR CANX

7.43e-06625210929008
Pubmed

Altered expression of glycoproteins on the cell surface of Jurkat cells during etoposide-induced apoptosis: shedding and intracellular translocation of glycoproteins.

CALR CANX

7.43e-06625219524015
Pubmed

Ethanol-induced intracellular calcium mobilization rapidly alters gene expression in the mouse blastocyst.

FGD6 DROSHA

1.04e-0572529502196
Pubmed

Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading.

CALR CANX

1.04e-05725211823531
Pubmed

Genes regulating MHC class I processing of antigen.

CALR CANX

1.39e-05825210047538
Pubmed

Deletion of Tmtc4 activates the unfolded protein response and causes postnatal hearing loss.

CALR CANX

1.39e-05825230188326
Pubmed

GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development.

CALR CANX

1.78e-05925216847323
Pubmed

Sensitive detection of idiotypic platelet-reactive alloantibodies by an electrical protein chip.

CALR CANX

1.78e-05925222572157
Pubmed

ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly.

CALR CANX

2.22e-05102529545232
Pubmed

Antigen recognition by autoreactive CD4⁺ thymocytes drives homeostasis of the thymic medulla.

CIITA HLA-DQA1

2.22e-051025223300712
Pubmed

Endoplasmic reticulum stress during the embryonic development of the central nervous system in the mouse.

CALR CANX

2.72e-051125217913437
Pubmed

Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.

ERBB3 CIITA

2.72e-051125218593762
Pubmed

Getting in and out from calnexin/calreticulin cycles.

CALR CANX

3.85e-051325218303019
Pubmed

Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.

HLA-DQA1 CANX

3.85e-05132529973410
Pubmed

Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins.

CALR CANX

5.18e-051525217090218
Pubmed

The fibroblast growth factor receptor substrate 3 adapter is a developmentally regulated microtubule-associated protein expressed in migrating and differentiated neurons.

CALR CANX

5.92e-051625219943849
Pubmed

Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.

CALR CANX

6.70e-051725232938586
Pubmed

Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.

CIITA HLA-DQA1

7.54e-051825211118314
Pubmed

Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.

CIITA HLA-DQA1

7.54e-051825210661406
Pubmed

Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.

ERBB3 HLA-DQA1

9.35e-052025218978792
Pubmed

Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.

ERBB3 CALR HLA-DQA1 CANX

1.35e-0437125425241761
Pubmed

EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.

ROCK1 CALR CANX

1.69e-0415025332423001
Pubmed

A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair.

CALR CANX MYO3B

1.79e-0415325327462432
Pubmed

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.

ROCK1 FHOD1 CANX NOL6

1.80e-0440025435013556
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

DIP2A ERBB3 CANX NOL6

2.17e-0442025428065597
Pubmed

Purification and identification of G protein-coupled receptor protein complexes under native conditions.

CALR CANX

2.28e-043125217215244
Pubmed

Hepatic lipase maturation: a partial proteome of interacting factors.

CALR CANX

2.28e-043125219136429
Pubmed

The unfolded protein response: integrating stress signals through the stress sensor IRE1α.

CALR CANX

2.28e-043125222013210
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

CALR DROSHA FHOD1 CANX

3.52e-0447725431300519
Pubmed

Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes.

CALR CANX

4.82e-04452521286667
Pubmed

Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells.

CALR CANX

5.04e-044625227751915
Pubmed

Multiple mouse chromosomal loci for dynein-based motility.

ERBB3 DNAH6

5.26e-04472528812413
Pubmed

The in vivo brain interactome of the amyloid precursor protein.

CALR CANX

5.95e-045025217934213
Cytoband12q13

ERBB3 P3H3

6.91e-047125212q13
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

ROCK1 FGD6

1.07e-02206142682
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PIGV FGD6 HLA-DQA1

3.50e-0511425384318a25a701331ccd5e68221239c543b9c0cc54
ToppCellCerebellum-Hematopoietic-MICROGLIA|Cerebellum / BrainAtlas - Mouse McCarroll V32

DENND1C CIITA HLA-DQA1

6.31e-0513925375cca1e6c1af289987d5d98455e9c6db81ecdd64
ToppCellCerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)|Cerebellum / BrainAtlas - Mouse McCarroll V32

DENND1C CIITA HLA-DQA1

6.31e-05139253de34e2f51f6fda638357abb662c111a20b83e70b
ToppCellCerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)-|Cerebellum / BrainAtlas - Mouse McCarroll V32

DENND1C CIITA HLA-DQA1

6.31e-05139253a077ce50f6d6746d80de35abed5b6dc35b1145b9
ToppCellCerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)|Cerebellum / BrainAtlas - Mouse McCarroll V32

DENND1C CIITA HLA-DQA1

6.31e-051392530ae117308bd10d3a7d2688794c69dc5a31cfca5f
ToppCellCerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)--|Cerebellum / BrainAtlas - Mouse McCarroll V32

DENND1C CIITA HLA-DQA1

6.31e-05139253fac6a3100a277efa1db250e0c576be1a0c901e6d
ToppCellCerebellum-Hematopoietic|Cerebellum / BrainAtlas - Mouse McCarroll V32

DENND1C CIITA HLA-DQA1

6.31e-051392533913c3828ad4cb5c71380519d0cf5f195e53c51d
ToppCellCOVID-19_Severe-B_cell|World / disease group, cell group and cell class

CDRT4 PDE6A HLA-DQA1

7.76e-051492539a9fcbf7e8a6811958f3fd2d36315e19ab2b1127
ToppCellPND01-Immune-Immune_Myeloid-DC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PDE6A CIITA HLA-DQA1

8.23e-05152253c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3
ToppCellPND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PDE6A CIITA HLA-DQA1

8.23e-05152253c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d
ToppCellPND01-Immune-Immune_Myeloid-DC-cDC2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PDE6A CIITA HLA-DQA1

8.23e-05152253cefc0ab592e99badf145fb95adf9906cb81be81c
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

8.39e-0515325391e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b
ToppCellfacs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERBB3 CIITA HLA-DQA1

8.39e-051532530ef7c45cdd854c79e527006034029767f8e108b2
ToppCellCOVID-19_Severe-B_cell|COVID-19_Severe / disease group, cell group and cell class

CDRT4 PDE6A HLA-DQA1

8.39e-05153253701a7d92ee7b22277c8462742a530347cc6f061a
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

8.39e-05153253f17f62646633cf95c810dcd5328978058741b276
ToppCellremission-unassigned|remission / disease stage, cell group and cell class

BCLAF3 ERBB3 SRCAP

8.56e-051542534130769829b838cc8a075c87ff6c187f0f507f8b
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

8.56e-051542535967a0a33456d5930fc492a700ebb015ac050abb
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

8.72e-051552539a27558c457f05808af07190b7a5006b047f1d58
ToppCellremission-unassigned|World / disease stage, cell group and cell class

BCLAF3 ERBB3 SRCAP

8.72e-05155253d81bec894381e3e2d6249a567e8108b8423e5c54
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

8.72e-05155253ab539c04f10276ae919d82b1c75f99a84eb695bf
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

8.72e-05155253fab281db4c275d51240b122be78713c839ba5a95
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

8.89e-05156253841d653d74c4de41d2f9a114f6ccb92d6a1ebc24
ToppCell5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CIITA FGD6 MYO3B

8.89e-05156253203ef22eb76bd2b829b027c30af0557080f4006c
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

8.89e-05156253a917b3e799a7b2a3c7f36af61f2b69292c0fb5c0
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CIITA SLC4A3 HLA-DQA1

8.89e-051562532474402f563e9e9f37351cfabc8c012e42a1d8c5
ToppCellsevere_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2)

CIITA SLC4A3 HLA-DQA1

9.06e-05157253ec1978e07e2214048d015d8bb793c1d9991f6e37
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

9.06e-05157253e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCellAT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

KDM5B ERBB3 MYO3B

9.23e-051582533bc51cfd37b289cc3e866b54ce55a298e5eff690
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

9.23e-05158253e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCellNasal_Brush-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X

HLA-DQA1 CANX

9.56e-0526252e83bba14028e7684beb3dd0ec5ecf8c88245a202
ToppCellChildren_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

CIITA SLC4A3 HLA-DQA1

9.76e-05161253cd41abb7ae659d3d314281783a0aaad562b26037
ToppCellChildren_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

CIITA SLC4A3 HLA-DQA1

9.94e-0516225386a0b9dabd150dc993bfc0f3344804de7f8e4042
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CDRT4 DNAH6 MYO3B

9.94e-05162253373513f9d0e5007b2e10a8b78d4909dcce9e3b62
ToppCell356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

KDM5B PDE6A SLC4A3

1.03e-04164253fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a
ToppCelldroplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DENND1C CIITA HLA-DQA1

1.05e-04165253479962ce1c3d6636ae62b6709635299748653801
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

1.07e-04166253b1bebcbe17386cb102b11d551e62d46156ce0c68
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

1.07e-04166253d373f1092e85eeb317a7406032b259f11e6adbe0
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

1.07e-04166253f453a1d545d59003d98485ac31e85e6cf451817c
ToppCellICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, Lineage and Cell Type

P3H3 SLC4A3 HLA-DQA1

1.09e-041672535b7b731944d888591279ef6167b3ae8cab3f6886
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

1.09e-04167253e44743b20a7435c579d8e999ddc4ca119d6753f2
ToppCellsevere-Myeloid-mDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CIITA SLC4A3 HLA-DQA1

1.09e-0416725350b1cea9048bd8df9aff3fb9a548443f950d1090
ToppCellsevere-Myeloid-mDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CIITA SLC4A3 HLA-DQA1

1.11e-04168253eff37a92d41624924201372cc09f9eb07b60aec1
ToppCell10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

SLC4A3 HLA-DQA1 MYO3B

1.13e-04169253319511ea57bbd72c2d95e8516d093689df67a912
ToppCellfacs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERBB3 CIITA HLA-DQA1

1.13e-04169253befb9b1618ea30fbf8983bcc493853da53b809c3
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SRCAP CIITA HLA-DQA1

1.13e-041692534de0c60f3c163b7823f739ebda4e0afc68346628
ToppCellfacs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERBB3 CIITA HLA-DQA1

1.13e-04169253d18b823836ca6fba79a2d2f10cb9966fa2623af2
ToppCell10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.15e-0417025359cb1262ff319349d42b11afbec2a9035b7b79f2
ToppCelldroplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND1C CIITA HLA-DQA1

1.15e-041702536210ee3bf29059e6149c047bb7e02c5f59441519
ToppCell10x3'2.3-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ERBB3 CIITA HLA-DQA1

1.17e-0417125304346d4eb726875e3537e215ea081a0318ca4ddd
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CIITA SLC4A3 HLA-DQA1

1.17e-04171253c2b7bbabc8f9afa8a1157b567d5f962d4b242919
ToppCellChildren_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

CIITA SLC4A3 HLA-DQA1

1.17e-041712536a5ac0f56bd7b4543be103100fb735ca6bc5b8bf
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CIITA SLC4A3 HLA-DQA1

1.19e-041722533f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CIITA SLC4A3 HLA-DQA1

1.21e-04173253d13ae4046a25ee0fb492ddedf44583a879a432e9
ToppCellnormal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass

CALR HLA-DQA1 MYO3B

1.21e-041732531e8a43ff32eab95857c794e0bf4f0b0dba155b4a
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

1.21e-041732539c7386bf0a899882c733f0b4921a96afde032a7d
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

1.21e-04173253a55f310c533432e9e26e400026a5b47245152976
ToppCellmild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

CIITA SLC4A3 HLA-DQA1

1.21e-0417325371dc0051c87b84e3cf13cde8858166f2a474b5dc
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DENND1C CIITA HLA-DQA1

1.23e-041742531b2a2129c08bac01fc638692313b196759a1e0d7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DENND1C CIITA HLA-DQA1

1.23e-041742535bde24eb588dc588efc413811379548120ec0c7f
ToppCell10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.25e-041752531c48eec300d5a6d4a810947b995af3b8c0a5a601
ToppCell10x5'v1-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CIITA SLC4A3 HLA-DQA1

1.27e-04176253fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733
ToppCell3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.27e-0417625372a3bbab0540ae3e3c94b9573cdb9298a024dbc4
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE6A CIITA HLA-DQA1

1.31e-04178253ba5a477257877f4a15a91c1762ffcc6f2e9f7357
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE6A CIITA HLA-DQA1

1.31e-041782535634c1fbc817758092af4feafff94d107412d89b
ToppCell3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DENND1C CIITA HLA-DQA1

1.34e-04179253ce95b601bf17ae8167d382a105384b9e65e9407f
ToppCell10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SRCAP SLC4A3 HLA-DQA1

1.34e-04179253140dd7dbac48f5f07279f31bf971d7fbd41fa18b
ToppCellmild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2)

CIITA SLC4A3 HLA-DQA1

1.36e-0418025368d1c867734fb2977b01ac686b20bf602f9a6b72
ToppCell3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.38e-0418125366d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class

DENND1C CIITA HLA-DQA1

1.38e-04181253193ee02f547a218b2fc13e1174ea4cff4f8a3450
ToppCell3'_v3-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.43e-04183253c94ee9f35b21252e1ab5ab15b6a2ce69a7d753f7
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.43e-04183253f482e4fe011fa450a475034b1e25587233855bdb
ToppCell10x5'v1-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CALR HLA-DQA1 CANX

1.43e-04183253c6cac433ea7a3d60728efdc7051e09e01bb3ade5
ToppCell3'_v3-GI_small-bowel-Myeloid_Dendritic|GI_small-bowel / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.43e-041832536109199cf25b28831193a5ed7925b5bf38c6eb43
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

1.45e-04184253a45980306c4e697a2703bed72a7b48fb23d942f4
ToppCellmild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CIITA SLC4A3 HLA-DQA1

1.45e-041842538b37c00d59d9992d3b43268991da7bb94646c70e
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue

CIITA FGD6 HLA-DQA1

1.45e-04184253ee295f6fa898da53883e1358b17f2c2dd177e9a7
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

1.45e-041842531c56378b3888c46258d446b47de4d6282fe74b0d
ToppCell10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.47e-04185253f78be85dd6e443abb7af20f98ff351c1131ece4d
ToppCellfacs-Kidney-nan-18m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND1C CIITA HLA-DQA1

1.47e-04185253a3b937163346d729115e6335336e33d3e71fccb0
ToppCellCOVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass

CIITA SLC4A3 HLA-DQA1

1.50e-0418625339457a7b43537f2c3e221f9375c95d4515424d7d
ToppCellCOVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters

KDM5B PIGV FGD6

1.50e-041862535954a1e3ffafb33f2a9bc87af3343f304fda4c92
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DENND1C CIITA HLA-DQA1

1.50e-04186253bec4767eaca28e41da373274704895eba75063e2
ToppCellwk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

DENND1C CIITA HLA-DQA1

1.50e-04186253de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54
ToppCellCOVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass

CIITA SLC4A3 HLA-DQA1

1.50e-0418625363a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.50e-04186253e823529ffd06352c6bdec102f221fdf27f7c7369
ToppCell10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KDM5B CALR CANX

1.50e-04186253895905f1d1a01ffd5617a0baa8818693a7e9cb3b
ToppCell3'_v3-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.52e-041872539f3db9f0e5de34aeabfe5984f675bc7a65435df7
ToppCellCOVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

CIITA SLC4A3 HLA-DQA1

1.52e-04187253936aaca144b79a809617cbe3058bf434a4b3d46a
ToppCell10x5'-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.52e-04187253ab9c9930341527122f26fe5544c5c4818d1fd1b5
ToppCellCOVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

CIITA SLC4A3 HLA-DQA1

1.52e-0418725355fe4e8b4f301876716c1af15c34d42164f2358e
ToppCellIPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class

ERBB3 SRCAP FGD6

1.52e-0418725319d6a404fc3651d98a93e3848e372df51a239c57
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

1.54e-041882538431991e68b8e9c5eb72212460f6da679ea3b85a
ToppCell3'_v3-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.54e-04188253239a2162a21d3339da7c1884ab76286346fbf97f
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

1.54e-04188253d8f10b3ad11bc99a63f44560e39791085256e5c8
ToppCell10x3'2.3-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CIITA SLC4A3 HLA-DQA1

1.54e-0418825315d8dc514d5da46f6af284e7c1c92c606712dae6
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CIITA SLC4A3 HLA-DQA1

1.57e-04189253c81b38cda4525254fe4fa137a4c9bc9abe0363bb
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

1.57e-04189253807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.59e-041902536892c603037b61ef88d6ca01b7592dc0d347d63b
ToppCell3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue

CIITA SLC4A3 HLA-DQA1

1.59e-04190253468525c05e38158a3b8a445882b2d63dfb1d2c63
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CIITA SLC4A3 HLA-DQA1

1.62e-041912534b94c8b0183ae07d173646b7e7e1d9db04ec9637
Drugdihydroxyaluminum aminoacetate

CALR CANX

1.73e-056252ctd:C007420
DrugAC1L1CUL

CALR CANX

5.18e-0510252CID000002070
DrugAcacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A

SRCAP CALR SLC4A3 FHOD1

5.73e-051952544324_DN
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

ROCK1 DIP2A CALR CANX

5.85e-051962541054_DN
DrugTenecteplase

CALR CANX

6.33e-0511252DB00031
DrugAntihemophilic Factor

CALR CANX

6.33e-0511252DB00025
DrugDBTC

CALR SLC4A3 CANX

6.91e-0573253CID000101938
Diseasecolon carcinoma (is_implicated_in)

CALR HLA-DQA1

2.27e-059242DOID:1520 (is_implicated_in)
Diseasejuvenile rheumatoid arthritis (is_implicated_in)

CIITA HLA-DQA1

4.92e-0513242DOID:676 (is_implicated_in)
Diseaseneuroblastoma, cutaneous melanoma

HLA-DQA1 NOL6

2.37e-0428242EFO_0000389, EFO_0000621
Diseaselongevity, healthspan, parental longevity

FGD6 HLA-DQA1

2.54e-0429242EFO_0004300, EFO_0007796, EFO_0009762
Diseaseresponse to antihypertensive drug

HLA-DQA1 MYO3B

5.10e-0441242EFO_0005405
Diseasenasopharynx carcinoma (is_marker_for)

ERBB3 CALR

5.61e-0443242DOID:9261 (is_marker_for)
Diseaselung adenocarcinoma (is_implicated_in)

ERBB3 CALR

7.28e-0449242DOID:3910 (is_implicated_in)
Diseaseasthma, chronic obstructive pulmonary disease

ERBB3 HLA-DQA1

7.58e-0450242EFO_0000341, MONDO_0004979
DiseaseNasal Cavity Polyp

ERBB3 HLA-DQA1

9.17e-0455242EFO_1000391
Diseaserheumatoid arthritis (is_implicated_in)

CIITA HLA-DQA1

1.02e-0358242DOID:7148 (is_implicated_in)
Diseasenarcolepsy-cataplexy syndrome

ERBB3 HLA-DQA1

1.05e-0359242MONDO_0016158
Diseaserheumatoid arthritis, COVID-19

ERBB3 HLA-DQA1

1.24e-0364242EFO_0000685, MONDO_0100096
Diseasesusceptibility to chronic sinus infection measurement

CIITA HLA-DQA1

1.40e-0368242EFO_0008419
Diseasemultiple sclerosis (is_implicated_in)

CIITA HLA-DQA1

1.61e-0373242DOID:2377 (is_implicated_in)
Diseaseasthma, allergic disease

ERBB3 HLA-DQA1

1.88e-0379242MONDO_0004979, MONDO_0005271
Diseaseage of onset of asthma

ERBB3 HLA-DQA1

1.88e-0379242OBA_2001001
DiseaseInhalant adrenergic use measurement

ERBB3 HLA-DQA1

2.76e-0396242EFO_0009941

Protein segments in the cluster

PeptideGeneStartEntry
DPWHKIPALDPEKLN

ERBB3

371

P21860
APLWPHDPDAKEKPL

SLC4A3

476

P48751
PFPEELPADLKHWKP

CIITA

146

P33076
LPADLKHWKPAEPPT

CIITA

151

P33076
PRWQPDDKKLPEPEP

DENND1C

601

Q8IV53
DKPLLKHWEPEIPAP

HLA-DQA1

196

P01909
MWKKIPPAAEPPAHL

ATXN7L2

451

Q5T6C5
PWILLSDDKGDHPPP

RILP

321

Q96NA2
EKRPWDHEPVKPKPL

P3H3

426

Q8IVL6
TGLPRKLLEKHDPWP

CDRT4

16

Q8N9R6
KEDIKVIPNPPPDHW

PDE6A

326

P16499
PVPEWDISQDPPKHK

NOL6

531

Q9H6R4
PPLHDVPKGDWRCPK

KDM5B

341

Q9UGL1
EKERPPKPEAPWLPT

DNAH6

3401

Q9C0G6
EPARNPKWKPEHSLP

BCLAF3

231

A2AJT9
SKPEDWDKPEHIPDP

CALR

231

P27797
WDKPEHIPDPDAKKP

CALR

236

P27797
PKIPDPEAVKPDDWD

CANX

291

P27824
LAKPPKDWHPLAQDT

DIP2A

491

Q14689
KEPLIPASPKAEPIW

FHOD1

516

Q9Y613
AARPPWEPPKTKLDE

DROSHA

461

Q9NRR4
KVPEPPRPKGHWDYL

SRCAP

126

Q6ZRS2
LKTVPWKPLAEDSPP

PIGV

431

Q9NUD9
ASEKPVWKLPHPILP

FGD6

561

Q6ZV73
AKPLWHVFKPPPALE

ROCK1

1246

Q13464
PDLPWPHPLGKEEEK

ZNF648

66

Q5T619
LEEWDPVPKPKPHVS

THEG

281

Q9P2T0
NPPPTLLHPEKWCEE

MYO3B

251

Q8WXR4